Johnston Associates

Overview

Johnston Associates is a private investment firm specializing in providing seed capital to emerging companies in the healthcare sector, with a particular emphasis on pharmaceuticals and biotechnology. Founded in 1968 by Robert F. Johnston, the firm has a history of launching and financing companies across various stages of development, from startups to publicly traded entities. Their portfolio includes companies in diagnostics, cell separations, imaging, drug discovery and delivery, toxic waste remediation, genetic engineering, and biopesticides. The firm nurtures young companies by offering financial assistance and key managerial and technical support, leveraging an extensive network in academia, venture capital, and medical communities to provide ongoing capital, R&D, regulatory, and personnel assistance needed for growth. Johnston Associates invests its own private capital and does not manage an investment fund, allowing for flexible investment horizons and return objectives. The firm typically invests in one enterprise a year, with investments ranging from $300,000 to over $3,000,000. Stringent criteria are applied to scientific achievement, market potential, uniqueness of approach, and the caliber of co-founders. Their interests include diagnostics, mitochondria, and biomarkers. The firm's investment strategy focuses on identifying and supporting innovative companies with high growth potential in the healthcare sector, aiming to drive advancements in medical technologies and services. Their track record includes founding and financing companies that have become leaders in their respective fields, demonstrating a commitment to fostering innovation and excellence in the healthcare industry.

Investment Focus

• Scientific achievement
• Market potential
• Uniqueness of approach
• Caliber of co-founders

Portfolio Companies